Transcriptomics

Dataset Information

0

Illumina RNA-seq of Human rhabdomyosarcoma Rh36 cell mouse xenograft tumors: effect of RITA, GANT61 and RITA/GANT61 combination treatments on xenograft tumor growth


ABSTRACT: Overactivation of the Hedgehog (HH) signaling pathway is implicated in many cancers. In this study, we demonstrate that the small molecule RITA, a p53 activator, effectively downregulates HH signaling in human medulloblastoma and rhabdomyosarcoma cells irrespective of p53. This is mediated by a ROS-independent activation of the MAP kinase JNK. We also show that in vitro RITA sensitized cells to the GLI antagonist GANT61, as co-administration of the two drugs had more pronounced effects on cell proliferation and apoptosis. In vivo administration of RITA or GANT61 suppressed rhabdomyosarcoma xenograft growth in nude mice; however, co-administration did not further enhance tumor suppression, even though cell proliferation was decreased. RITA was more potent than GANT61 in downregulating HH target gene expression; surprisingly, this suppressive effect was almost completely eliminated when the two drugs were administered together. Notably, RNA-seq demonstrated a broader response of pathways involved in cancer cell growth in the combination treatment, providing a plausible interpretation for tumor reduction in the absence of HH signaling downregulation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE161235 | GEO | 2020/11/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA675953 | ENA
2025-06-10 | PXD054802 | Pride
2016-02-04 | PXD002494 | Pride
2014-01-15 | E-GEOD-53464 | biostudies-arrayexpress
2022-01-21 | GSE178838 | GEO
2014-06-15 | E-GEOD-54936 | biostudies-arrayexpress
2017-04-13 | GSE97726 | GEO
2021-04-25 | PXD019346 | Pride
2014-01-15 | GSE53464 | GEO
2014-07-31 | E-GEOD-46045 | biostudies-arrayexpress